Drug litigation in review 2010 
By:
Tony Ogden
Published: January 4, 2011
Tags: Accutane, Allergan, antidepressant, Avandia, AztraZeneca, Botox, Botox litigation, Department of Justice, DOJ, epilepsy, failure to warn, GlaxoSmithKline, heart attack, hormone replacement therapy, hormone replacement therapy litigation, Johnson & Johnson, Levaquin, Neurontin, Paxil, Pfizer, Premarin, Prempro, Provera, Roche, Seroquel, Wyeth
Much like 2009, 2010 was a busy year for prescription drug suits.
Patient’s suicide doesn’t preclude Paxil lawsuit
By:
Pat Murphy
Published: July 28, 2010
Tags: Federal Tort Claims Act, negligence, Paxil
A Paxil user’s suicide did not constitute an intervening cause that would preclude the government’s liability for the negligence of its medical care providers, the 10th Circuit has ruled in reversing a summary judgment.
Glaxo said to have paid $1 billion over Paxil suits
By:
Tony Ogden
Published: July 23, 2010
Tags: birth defects, GlaxoSmithKline, Paxil
GlaxoSmithKline Plc has agreed to pay more than $1 billion to resolve more than 800 cases alleging its Paxil antidepressant caused birth defects in some users’ children, according to people familiar with the settlements.
Settlement in Paxil lawsuit filed by woman
By:
Tony Ogden
Published: July 20, 2010
Tags: Massachusetts, Paxil, wrongful death
A settlement has been reached in a lawsuit filed against a pharmaceutical company by a Watertown, Mass. woman who linked her prescribed use of Paxil to the death of her infant son, according to court files.
Scores of Paxil birth-defect cases settled
By:
Tony Ogden
Published: June 24, 2010
Tags: birth defects, GlaxoSmithKline, Paxil
The manufacturer of Paxil has agreed to settlements in nearly 200 individual cases claiming that the antidepressant caused birth defects.
Paxil suicide plaintiff can show causation
By:
Pat Murphy
Published: April 6, 2010
Tags: drug litigation, expert witness, Paxil, product liability
A product liability plaintiff could show that her brother’s suicide was the result of a drug maker’s failure to provide adequate warnings for the anti-depressant he started taking shortly before his death, a U.S. District Court in Indiana has ruled in denying summary judgment.
Learned intermediary doctrine bars Paxil suit
By:
Pat Murphy
Published: March 8, 2010
Tags: drug litigation, learned intermediary doctrine, Paxil, product liability
The “learned intermediary” doctrine applies to preclude liability in a wrongful death suit brought by a woman whose husband committed suicide while taking an anti-depressant manufactured by the defendant, the 11th Circuit has ruled in affirming judgment.
Paxil suicide claims not preempted
By:
Correy Stephenson
Published: February 24, 2010
Tags: drug litigation, failure to warn, federal preemption, Paxil, Wyeth v. Levine
A plaintiff’s Paxil suicide claims are not preempted, the 7th Circuit has ruled in reversing summary judgment for the drug manufacturer.
Personal injury news in review 2009
By:
Nora Tooher
Published: December 22, 2009
Tags: assisted living industry, Barton, Bettinger, Chinese drywall, Chrysler, GM bankruptcies, hormone replacement therapy, Paxil, sudden acceleration accidents, Toyota, Wyeth v. Levine, Yasmin, Yaz
Lawyers USA recaps the big news and notable moments in personal injury law during 2009 — from Supreme Court decisions to singing courtroom summations.
Glaxo said to have paid $1B to settle Paxil suits
By:
Pat Murphy
Published: December 14, 2009
Tags: Paxil, product liability
GlaxoSmithKline Plc has paid almost $1 billion to resolve lawsuits over Paxil since it introduced the antidepressant in 1993, including about $390 million for suicides or attempted suicides said to be linked to the drug, according to court records and people familiar with the cases.
NEW FREE WHITE PAPER: E-Discovery
This FREE e-report brought to you by Lawyers USA contains the latest tips for conducting thorough and successful electronic discovery for your trial in 2012. We’ve analyzed the latest court rulings and trends in e-discovery to help you and your clients avoid sanctions and win your case.
Click here to get your free White Paper today!
